Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study

BACKGROUND: There is no consensus on the recommended duration of and optimal time to stop azathioprine (AZA) therapy in inflammatory bowel disease (IBD). Determining the optimal duration and cessation time can help to balance the risks of long-term intake with the possibility of relapse after cessat...

Descripción completa

Detalles Bibliográficos
Autores principales: Crepaldi, Martina, Maniero, Daria, Massano, Alessandro, Pavanato, Margherita, Barberio, Brigida, Savarino, Edoardo Vincenzo, Zingone, Fabiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401657/
https://www.ncbi.nlm.nih.gov/pubmed/37545640
http://dx.doi.org/10.3748/wjg.v29.i27.4334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401657/
https://www.ncbi.nlm.nih.gov/pubmed/37545640
http://dx.doi.org/10.3748/wjg.v29.i27.4334

Ejemplares similares